Bonum Therapeutics
Biotechnology ResearchWashington, United States11-50 Employees
Bonum Therapeutics is focused on a proven technology that utilizes regulation to create targeted, highly active, and less toxic medicines.
Insights
Gathering insights about Bonum Therapeutics…
Similar companies to Bonum Therapeutics
Roche
93K
$1BSanofi
87K$1BJohnson & Johnson
103K$1BPfizer
102K$1BAstraZeneca
73K$1BGenentech
18K$1BAbbVie
54K$1BBiogen
8.1K$1BGilead Sciences
15K$1BNovartis
78K$1BAmgen
36K$1B
Bonum Therapeutics Tech Stack
Media & News
Bonum Therapeutics's Email Address Formats
Bonum Therapeutics uses at least 1 format(s):
| Bonum Therapeutics Email Formats | Percentage |
| Last@bonumtx.com | 50% |
| Last@bonumtx.com | 50% |
Frequently Asked Questions
Where is Bonum Therapeutics's headquarters located?
Bonum Therapeutics's main headquarters is located at 1616 Eastlake Avenue E Suite 400 Seattle, WA 98102 US. The company has employees across 2 continents, including North AmericaEurope. What is Bonum Therapeutics's official website and social media links?
Bonum Therapeutics's official website is bonumtx.com and has social profiles on LinkedIn.How much revenue does Bonum Therapeutics generate?
As of October 2024, Bonum Therapeutics's annual revenue reached $3.8M. What is Bonum Therapeutics's SIC code NAICS code?
Bonum Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Bonum Therapeutics have currently?
As of October 2024, Bonum Therapeutics has approximately 33 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Of Preclinical Development: C. L. Y.Founder And Ceo: J. M.Cbo: N. P.. Explore Bonum Therapeutics's employee directory with LeadIQ.What industry does Bonum Therapeutics belong to?
Bonum Therapeutics operates in the Biotechnology Research industry. What is Bonum Therapeutics's email format?
Bonum Therapeutics's email format typically follows the pattern of . Find more Bonum Therapeutics email formats with LeadIQ. How much funding has Bonum Therapeutics raised to date?
As of October 2024, Bonum Therapeutics has raised $93M in funding. The last funding round occurred on Nov 15, 2022 for $93M.When was Bonum Therapeutics founded?
Bonum Therapeutics was founded in 2021.
Company Overview
- Headquarters
- 1616 Eastlake Avenue E Suite 400 Seattle, WA 98102 US
- Website
- bonumtx.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2021
- Employees
- 11-50
Funding & Financials
- $93M
Bonum Therapeutics has raised a total of $93M of funding over 1 rounds. Their latest funding round was raised on Nov 15, 2022 in the amount of $93M.
- $10M
Bonum Therapeutics's revenue is in the range of $10M
Funding & Financials
- $93M
Bonum Therapeutics has raised a total of $93M of funding over 1 rounds. Their latest funding round was raised on Nov 15, 2022 in the amount of $93M.
- $10M
Bonum Therapeutics's revenue is in the range of $10M
Company Leadership
C. L. Y.Vice President Of Preclinical Development- J. M.Founder And Ceo
- N. P.Cbo
D. H.Cso
J. K.Vice President, Biology
Employee Directory
- D. B.Senior Director, Protein Sciences
- L. L.Senior Director, Antibody Discovery
- R. K.Director Of Operations
- N. K.Lab Manager
- D. C.Principal Scientist
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
